Literature DB >> 21426103

Therapeutic potential of boron-containing compounds.

Stephen J Baker1, Charles Z Ding, Tsutomu Akama, Yong-Kang Zhang, Vincent Hernandez, Yi Xia.   

Abstract

Relative to carbon, hydrogen, nitrogen and oxygen, very little is currently known about boron in therapeutics. In addition, there are very few boron-containing natural products identified to date to serve as leads for medicinal chemists. Perceived risks of using boron and lack of synthetic methods to handle boron-containing compounds have caused the medicinal chemistry community to shy away from using the atom. However, physical, chemical and biological properties of boron offer medicinal chemists a rare opportunity to explore and pioneer new areas of drug discovery. Boron therapeutics are emerging that show different modes of inhibition against a variety of biological targets. With one boron-containing therapeutic agent on the market and several more in various stages of clinical trials, the occurrence of this class of compound is likely to grow over the next decade and boron could become widely accepted as a useful element in future drug discovery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 21426103     DOI: 10.4155/fmc.09.71

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  47 in total

1.  Isocyanide-Based Multicomponent Reactions of Free Phenylboronic Acids.

Authors:  Constantinos G Neochoritis; Tryfon Zarganes-Tzitzikas; Michaela Novotná; Tatiana Mitríková; Zefeng Wang; Katarzyna Kurpiewska; Justyna Kalinowska-Tłuścik; Alexander Dömling
Journal:  Eur J Chem       Date:  2019-08-15

2.  Antimalarial Benzoxaboroles Target Plasmodium falciparum Leucyl-tRNA Synthetase.

Authors:  Ebere Sonoiki; Andres Palencia; Denghui Guo; Vida Ahyong; Chen Dong; Xianfeng Li; Vincent S Hernandez; Yong-Kang Zhang; Wai Choi; Jiri Gut; Jennifer Legac; Roland Cooper; M R K Alley; Yvonne R Freund; Joseph DeRisi; Stephen Cusack; Philip J Rosenthal
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

3.  A Divalent Protecting Group for Benzoxaboroles.

Authors:  Brett Vanveller; Matthew R Aronoff; Ronald T Raines
Journal:  RSC Adv       Date:  2013-11-28       Impact factor: 3.361

4.  Click Chemistry in Lead Optimization of Boronic Acids as β-Lactamase Inhibitors.

Authors:  Emilia Caselli; Chiara Romagnoli; Roza Vahabi; Magdalena A Taracila; Robert A Bonomo; Fabio Prati
Journal:  J Med Chem       Date:  2015-07-10       Impact factor: 7.446

5.  Accessing Elaborated 2,1-Borazaronaphthalene Cores Using Photoredox/Nickel Dual-Catalytic Functionalization.

Authors:  Matthieu Jouffroy; Geraint H M Davies; Gary A Molander
Journal:  Org Lett       Date:  2016-03-17       Impact factor: 6.005

Review 6.  Molecular recognition with boronic acids-applications in chemical biology.

Authors:  Gillian F Whyte; Ramon Vilar; Rudiger Woscholski
Journal:  J Chem Biol       Date:  2013-06-01

7.  Detection of boronic acids through excited-state intramolecular proton-transfer fluorescence.

Authors:  Matthew R Aronoff; Brett VanVeller; Ronald T Raines
Journal:  Org Lett       Date:  2013-10-07       Impact factor: 6.005

Review 8.  Recent advances in malaria drug discovery.

Authors:  Marco A Biamonte; Jutta Wanner; Karine G Le Roch
Journal:  Bioorg Med Chem Lett       Date:  2013-03-27       Impact factor: 2.823

Review 9.  Boron chemicals in diagnosis and therapeutics.

Authors:  Bhaskar C Das; Pritam Thapa; Radha Karki; Caroline Schinke; Sasmita Das; Suman Kambhampati; Sushanta K Banerjee; Peter Van Veldhuizen; Amit Verma; Louis M Weiss; Todd Evans
Journal:  Future Med Chem       Date:  2013-04       Impact factor: 3.808

Review 10.  From the Test Tube to the Treatment Room: Fundamentals of Boron-containing Compounds and their Relevance to Dermatology.

Authors:  James Q Del Rosso; Jacob J Plattner
Journal:  J Clin Aesthet Dermatol       Date:  2014-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.